Agenus Science Pipeline + technologies Activities What we do Financial How we build value News Our latest updates Contact How to get in touch Agenus - mark AT AGENUS, WE BELIEVE THE BEST PATH FOR TREATING DISEASE IS THROUGH ACTIVATING OUR OWN BODY’S NATURAL MECHANISMS. That’s why for 20 years, we’ve focused on building technologies and a product pipeline aimed at treating cancer and infectious disease by helping the body’s immune system target diseased cells with precision. Agenus Reports Second Quarter 2014 Financial Results SEPTEMBER 2, 2014 Agenus to Participate in Two Upcoming Investor Conferences READ MORE 1 2 3 4 © 2014 Agenus Inc. All rights reserved. PRIVACY POLICY TERMS & CONDITIONS CONTACT US

Agenus SciencePipeline + technologies Pipeline Checkpoint Antibody Platform Prophage QS-21 HerpV ActivitiesWhat we do Our Work In/Out Licensing Leadership Careers FinancialHow we build value NewsOur latest updates Press Releases Webcasts Publications ContactHow to get in touch About Us Our Work In/Out Licensing Leadership Careers Executive Leadership Agenus’ executive leadership & board of directors are a committed & inspiring force, setting company direction & outlining a path to success. Individually, they each bring strong & varied knowledge, experience & skills to guide the company’s efforts, strategy & performance. Collectively, they share one common trait: an unwavering belief in the promise of immunotherapy & in the importance of Agenus’ role in fulfilling that promise. Garo H. Armen, PhD Chairman & CEO Jonae R. Barnes Vice President, Investor Relations & Corporate Communications Ozer Baysal Chief Business Officer Robert F. Burns, PhD President, 4-Antibody John Cerio Vice President, Human Resources & Administration Christine Klaskin Vice President, Finance & Principal Financial Officer Janice McCourt Vice President, Business Development Stephen Monks, PhD Vice President, Manufacturing, Process & Analytical Technologies Robert Stein, MD, PhD Chief Scientific Officer Karen Valentine, JD Vice President & General Counsel Directors Garo H. Armen, PhD Chairman & Chief Executive Officer, Agenus Brian Corvese President & Founder, Vencor Capital Tom Dechaene Advisor to Telecommunications, Media, & High Technology Industries Wadih Jordan President, NearEast Pharma Shahzad Malik General Partner, Advent Venture Partners Shalini Sharp Chief Financial Officer & Senior Vice President of Finance, Ultragenyx Pharmaceutical Timothy R. Wright Director, The Ohio State University Comprehensive Cancer Center Drug Development Institute © 2014 Agenus Inc. All rights reserved. Privacy Policy Terms & Conditions Contact Us